Radiation Therapy for Primary Eyelid Cancers in Tunisia |
Belaid, A
(Radiation oncology department, Salah Azaiez Institute)
Nasr, C (Radiation oncology department, Salah Azaiez Institute) Benna, M (Radiation oncology department, Salah Azaiez Institute) Cherif, A (Radiation oncology department, Salah Azaiez Institute) Jmour, O (Radiation oncology department, Salah Azaiez Institute) Bouguila, H (Ophtalmology department A, Hedi Raies Institute) Benna, F (Radiation oncology department, Salah Azaiez Institute) |
1 | Muqit MM, Foot B, Walters SJ, et al (2013). Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma. Br J Ophtalmol, 97, 47-51. DOI |
2 | Neale RE, Weissenborn S, Abeni D, et al (2013). Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 22, 719-27. DOI |
3 | Pfeiffer ML, Savar A, Esmaeli B (2013). Sentinel lymph node biopsy for eyelid and conjunctival tumors: what have we learned in the past decade. Ophtal Plast Reconstr Surg, 29, 57-62. DOI |
4 | Schlienger P, Brunin F, Desjardins L, et al (1996). External radiotherapy for carcinoma of the eyelid: report of 850 cases treated. Int J Radiat Oncol Biol Phys, 34, 277-87. DOI |
5 | Deo SV, Shukla NK, Singh M, et al (2012). Locally advanced sebaceous cell carcinoma (T3) of eyelid: incidence and pattern of nodal metastases and combined modality management approach. Orbit, 31, 150-4. DOI |
6 | Deprez M, Uffer S (2009). Clinicopathological features of eyelid skin tumors: a retrospective study of 5504 cases and review of literature. Am J Dermatopathol, 3, 256-62. |
7 | Ainbinder DJ, Esmaeli B, Groo SC, Finger PT, Brooks JP (2009). Introduction of the 7th edition eyelid carcinoma classification system from the American Joint Committee on Cancer-International Union Against Cancer staging manual. Arch Pathol Lab Med, 133, 1256-61. |
8 | Esmaeli B, Nasser QJ, Cruz H, et al (2012). American Joint Comittee on Cancer T cateogory for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. Ophtalmol, 119, 1078-82. DOI |
9 | Gaskin BJ, Fernando BS, Sullivan CA, et al (2011). The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome. Br J Ophtalmol, 95, 1686-90. DOI |
10 | Jackson JE, Dickie GJ, Wiltshire KL, et al (2009). Radiotherapy for perineural invasion in cutaneous head and neck carcinomas : toward a risk adapted treatment approach. Head Neck, 31, 604-10. DOI |
11 | Jardel P, Caujolle JP, Gastaud L, et al (2015). Malignant tumours of the eye: Epidemiology, diagnostic methods and radiotherapy. Cancer Radiother, 19, 762-74. DOI |
12 | Knani L, Romdhane O, Ben Rayana N, Mahjoub H, Ben Hadj Hamida F (2014). Clinical study and risk factors for recurrence of basal cell carcinoma of the eyelid: results of a Tunisian series and review of the literature. J Fr Ophtalmol, 37, 107-14. DOI |
13 | Krengli M, Masini L, Comoli AM, et al (2014). Interstitial brachytherapy for eyelid carcinoma: outcome analysis in 60 patients. Strahlenther Onkol, 190, 245-9. DOI |
14 | Mareco V, Bujor L, Abrunhosa-Branquinho AN, et al (2015). Interstitial high-dose-rate brachytherapy in eyelid cancer. Brachytherapy, 14, 554-64. DOI |
15 | Amdur RJ, Kalbaugh KJ, Ewald LM, et al (1992). Radiation therapy for skin cancer near the eye: kilovoltage x-rays versus electrons. Int J Radiat Oncol Biol Phys, 23(4), 769-79. DOI |
16 | Herbert HM, Sun MT, Selva D, et al (2014). Merkel cell carcinoma of the eyelid: management and prognosis. JAMA Ophthalmol, 132, 197-204. DOI |
17 | Ho SF, Brown L, Bamford M, et al (2012). Five years review of periocular basal cell carcinoma and proposed follow-up protocol. Eye, 27, 78-83. |
18 | Iuliano A, Strianese D, Uccello G, et al (2012). Risk factors for orbital exenteration in periocular basal cell carcinoma. Am J Ophthalmol, 153, 238-41. DOI |
19 | Connor M, Droll L, Ivan D, et al (2011). Management of perineural invasion in sebaceous carcinoma of the eyelid. Ophtal Plast Reconstr Surg, 27, 356-9. DOI |
20 | Cox JD, Stetz J, Pajak TF (1995). Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 31, 1341-6. DOI |
21 | Shields JA, Demirci H, Marr BP, et al (2004). Sebeceous carcinoma of the eyelids: personal experience with 60 cases. Ophtalmol, 111, 2151-7. DOI |
22 | Yin VT, Merritt HA, Sniegowski M, Esmaeli B (2015). Eyelid and ocular surface carcinoma: diagnosis and management. Clin Dermatol, 33, 159-69. DOI |
23 | Hata M, Koike I, Omura M, et al (2012). Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid. Int J Radiat Oncol Biol Phys, 82, 605-11. DOI |